International Historical Cash Flow
| IBT Stock | 704.00 4.00 0.57% |
Analysis of International Biotechnology cash flow over time is an excellent tool to project International Biotechnology future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 7.6 M or Capital Expenditures of 47.6 M as it is a great indicator of International Biotechnology ability to facilitate future growth, repay debt on time or pay out dividends.
International |
About International Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in International balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which International's non-liquid assets can be easily converted into cash.
International Biotechnology Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by International Biotechnology to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of International Biotechnology operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from International Biotechnology's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into International Biotechnology current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in International Biotechnology Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At present, International Biotechnology's Free Cash Flow is projected to increase significantly based on the last few years of reporting. The current year's Other Non Cash Items is expected to grow to about 7.6 M, whereas Change In Working Capital is forecasted to decline to (768.6 K).
International Biotechnology cash flow statement Correlations
Click cells to compare fundamentals
International Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
International Biotechnology cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | (1.1M) | 23.6M | (3.5M) | (10.0M) | (16.2M) | (15.4M) | |
| Change In Cash | (18.7M) | (2.5M) | (19.7M) | 7.5M | 43.2M | 45.3M | |
| Free Cash Flow | (9.6M) | (14.5M) | 1.1M | 27.3M | 45.4M | 47.6M | |
| Change In Working Capital | (63.0M) | (42.4M) | 228K | 22.1M | (732K) | (768.6K) | |
| Begin Period Cash Flow | 886K | (17.8M) | (20.3M) | (40.0M) | (32.7M) | (31.1M) | |
| Other Cashflows From Financing Activities | 441K | 23.6M | (3.5M) | (10.0M) | (11.5M) | (10.9M) | |
| Other Non Cash Items | (170K) | (162K) | 23.2M | (1.7M) | 7.2M | 7.6M | |
| Total Cash From Operating Activities | (9.6M) | (14.5M) | 1.1M | 27.3M | 45.4M | 47.6M | |
| Net Income | 53.6M | 28.0M | (22.3M) | 6.9M | 38.9M | 20.4M | |
| Total Cash From Financing Activities | (9.1M) | 12.0M | (16.4M) | (21.4M) | (2.2M) | (2.3M) | |
| End Period Cash Flow | (17.8M) | (20.3M) | (40.0M) | (32.5M) | 10.4M | 11.0M | |
| Change To Account Receivables | 2.5M | (781K) | (33K) | (25K) | 14K | 13.3K | |
| Dividends Paid | 9.5M | 11.6M | 12.9M | 11.4M | 10.8M | 11.1M | |
| Change To Operating Activities | 25.7M | (64.9M) | (43.1M) | 19.0M | 21.9M | 23.0M | |
| Change To Liabilities | 913K | (568K) | 1.5M | 261K | 234.9K | 152.6K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in International Stock
The Cash Flow Statement is a financial statement that shows how changes in International balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which International's non-liquid assets can be easily converted into cash.